Exercise As a Prevention for Substance Use Disorder: A Review of Sex Differences and Neurobiological Mechanisms
Overview
Affiliations
Purpose Of Review: This report provides an update on clinical and preclinical findings for the efficacy of exercise to prevent substance use disorder with a focus on recent evidence for sex differences and neurobiological mechanisms.
Recent Findings: Exercise/physical activity is associated with decreased drug use in humans. Preclinical results further indicate that exercise decreases vulnerability to drug use and the development of features of substance use disorder, and suggest that females have an enhanced sensitivity to its reward-substitution effects. However, certain exercise conditions may sensitize the reward pathway and enhance vulnerability suggesting that parallel observations in humans (e.g., increased prescription opioid misuse and heroin use in high-school athletes) may be biologically-based.
Summary: Exercise is a promising prevention strategy for substance use disorder. Further work is needed to establish its efficacy as a sex-specific strategy using larger samples, and to understand the exercise conditions that induce beneficial versus risk-enhancing effects.
Towers E, Shapiro D, Abel J, Bakhti-Suroosh A, Kupkova K, Auble D Biol Psychiatry Glob Open Sci. 2023; 3(4):734-745.
PMID: 37881559 PMC: 10593899. DOI: 10.1016/j.bpsgos.2023.01.007.
Ketogenic diet enhances the effects of oxycodone in mice.
Trinko R, Diaz D, Foscue E, Thompson S, Taylor J, DiLeone R Sci Rep. 2023; 13(1):7507.
PMID: 37160959 PMC: 10170077. DOI: 10.1038/s41598-023-33458-8.
The Role of Physical Exercise in Opioid Substitution Therapy: Mechanisms of Sequential Effects.
Psarianos A, Chryssanthopoulos C, Paparrigopoulos T, Philippou A Int J Mol Sci. 2023; 24(5).
PMID: 36902190 PMC: 10003472. DOI: 10.3390/ijms24054763.
Lynch W, Bakhti-Suroosh A, Abel J Transl Psychiatry. 2022; 12(1):425.
PMID: 36192388 PMC: 9529880. DOI: 10.1038/s41398-022-02180-w.
He Y, Madeo G, Liang Y, Zhang C, Hempel B, Liu X Sci Adv. 2022; 8(35):eabo1440.
PMID: 36054363 PMC: 10848951. DOI: 10.1126/sciadv.abo1440.